Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
25.06
0.00 (0.00%)
Aug 5, 2026, 8:02 AM EDT - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $2.84 billion as of August 5, 2026. Its market cap has increased by 197.87% in one year.
Market Cap
2.84B
Enterprise Value
2.26B
1-Year Change
197.87%
Ranking
Category
Stock Price
$25.06
ChartMarket Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.84B, an increase of 2,447.83%. That is a compound annual growth rate of 74.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 2.84B | 19.75% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AtaiBeckley | 2.66B |
| Kodiak Sciences | 2.60B |
| Trevi Therapeutics | 2.59B |
| Beam Therapeutics | 2.54B |
| Tarsus Pharmaceuticals | 2.54B |
| Ultragenyx Pharmaceutical | 2.45B |
| Nurix Therapeutics | 2.41B |
| Nektar Therapeutics | 2.39B |